SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-334565
Filing Date
2017-11-07
Accepted
2017-11-06 18:07:04
Documents
4
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d471723d8k.htm 8-K 16342
2 EX-99.1 d471723dex991.htm EX-99.1 76121
3 EX-99.2 d471723dex992.htm EX-99.2 81669
4 GRAPHIC g471723g1103055630060.jpg GRAPHIC 3537
  Complete submission text file 0001193125-17-334565.txt   180252
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 171180557
SIC: 2834 Pharmaceutical Preparations